We are live on ! Find out more
PALI icon

Palisade Bio

1 hedge funds and large institutions have $5.63M invested in Palisade Bio in 2013 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
1
Holders Change
+1
Holders Change %
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.09M +$3.06M +2 New
CS
2
Credit Suisse
Switzerland
$782K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$329K
California Public Employees Retirement System
4
California Public Employees Retirement System
California
$232K
BFA
5
BlackRock Fund Advisors
California
$207K
D.E. Shaw & Co
6
D.E. Shaw & Co
New York
$185K
Northern Trust
7
Northern Trust
Illinois
$144K
BRWA
8
B. Riley Wealth Advisors
Florida
$132K
FAAS
9
First Allied Advisory Services
California
$127K
DC
10
Davenport & Co
Virginia
$70K
GT
11
Greenleaf Trust
Michigan
$60K
LTFS
12
Ladenburg Thalmann Financial Services
Florida
$59K
State Street
13
State Street
Massachusetts
$43K
GC
14
Guggenheim Capital
Illinois
$34K
KFS
15
KMS Financial Services
Washington
$28K
LPL Financial
16
LPL Financial
California
$24K
BA
17
BlackRock Advisors
Delaware
$22K
U
18
UBS
Switzerland
$22K
Commonwealth Equity Services
19
Commonwealth Equity Services
Massachusetts
$16K
GIA
20
GHP Investment Advisors
Colorado
$15K
Manulife (Manufacturers Life Insurance)
21
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$5K
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$4K

PALI Hedge Fund Activity: Q2 2013 in Review

1 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2013, worth a combined $5.63M.

Buyers outnumbered sellers: 1 fund opened new PALI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Palisade Bio (PALI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.63M of Palisade Bio stock for Q2 2013.
  • 1 fund opened new Palisade Bio positions in Q2 2013 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q2 2013.